ERBB3 and breast carcinoma: Resistance to PI3K inhibition in brain metastases of breast cancer was rescued by inhibition of HER3 activity both in vitro and in vivo [47], suggesting that activation of the PI3K-Akt pathway by HER3 contributes to brain metastasis.